SIRT3 and Parkinson disease: As observed above, NAD+ deficit could impair SIRT3 activity [211], thus increasing CyPD acetylation, which in turn is more prone to activate the mPTP [121], a hypothesis that has not yet been tested in animal or cellular models of PD.